Scott D. Sandell is an Independent Director of the Company. Mr. Sandell is Managing General Partner at global venture capital firm New Enterprise Associates, Inc. (“NEA”). As a General Partner since 2000 and Co-Managing General Partner from 2015 to 2017, Mr. Sandell served as head of the firm’s technology investing practice for 10 years and has led NEA’s China investing activities for over a decade. Prior to joining NEA in 1996, Mr. Sandell worked as a Product Manager for Windows 95 at Microsoft Corporation. Mr. Sandell started his career at the Boston Consulting Group, a global management consulting firm, and later joined C-ATS Software, Inc., a software development company. Mr. Sandell currently serves on the boards of various private companies. He previously served on the boards of, among others, Data Domain, Inc., Fusion-io, Inc., Neoteris, Inc., NetIQ Corporation, Playdom, Inc., Spreadtrum Communications, Inc., Tableau Software Inc., WebEx Communications, Inc., and Workday, Inc. Mr. Sandell also currently serves on the Board of Advisors for the Thayer School of Engineering at Dartmouth and is a former Chairman of the National Venture Capital Association, a trade organization for venture capital and private equity firms. Mr. Sandell holds an A.B. from Dartmouth College and an M.B.A. from Stanford University.
What is Scott D. Sandell's net worth?
The estimated net worth of Scott D. Sandell is at least $2.87 million as of October 2nd, 2025. Mr. Sandell owns 488,702 shares of Ardelyx stock worth more than $2,871,124 as of December 4th. This net worth approximation does not reflect any other investments that Mr. Sandell may own. Learn More about Scott D. Sandell's net worth.
How do I contact Scott D. Sandell?
Has Scott D. Sandell been buying or selling shares of Ardelyx?
Scott D. Sandell has not been actively trading shares of Ardelyx during the last ninety days. Most recently, Scott D. Sandell sold 1,000,735 shares of the business's stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $1.24, for a transaction totalling $1,240,911.40. Learn More on Scott D. Sandell's trading history.
Who are Ardelyx's active insiders?
Ardelyx's insider roster includes Robert Blanks (Insider), Eric Foster (Chief Commercial Officer), Elizabeth Grammer (Insider), Jeffrey Jacobs (Insider), Mike Kelliher (Insider), David Mott (Director), Michael Raab (CEO), Justin Renz (Chief Financial & Operations Officer), Susan Rodriguez (Insider), David Rosenbaum (Insider), Scott Sandell (Major Shareholder), and Laura Williams (Chief Medical Officer). Learn More on Ardelyx's active insiders.
Are insiders buying or selling shares of Ardelyx?
In the last year, Ardelyx insiders bought shares 7 times. They purchased a total of 1,371,406 shares worth more than $5,780,176.94. In the last year, insiders at the biopharmaceutical company sold shares 26 times. They sold a total of 580,304 shares worth more than $3,050,503.57. The most recent insider tranaction occured on November, 21st when insider Elizabeth A Grammer sold 5,995 shares worth more than $33,212.30. Insiders at Ardelyx own 4.8% of the company.
Learn More about insider trades at Ardelyx. Information on this page was last updated on 11/21/2025.
